The Reproductive Infectious Diseases Program is a network of health professionals, researchers and knowledge users dedicated to advancing reproductive infectious diseases care and research internationally. Through local, national and global research collaborations, the team works to address emergent knowledge gaps and provide evidence-based guidance for the prevention, treatment, and care of reproductive infectious diseases.

Highlighted Research

NOVA-HIV

A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living with HIV

The goal of this study is to explore reduced dosing of the nonavalent HPV vaccine in women living with HIV. This multi-site phase IV clinical trial will carry on from our previous HPV in HIV studies. Investigators intend to begin recruiting for the NOVA-HIV study within the first half of 2023.

Antenatal Serostudies

Canadian Population Serological Survey Utilizing Antenatal Serum Samples

This national project will improve our understanding of the seroprevalence of antibodies to SARS-CoV-2 using antenatal blood samples which are routinely taken as part of prenatal care. Pregnant women are representative of generally healthy adults from ages 18-45 years from all socioeconomic and cultural backgrounds; use of these existing samples will provide a window into the generally healthy adult population of Canada as a whole.

COVERED Vaccine Registry

Canadian COVID-19 Vaccine Registry for Pregnant and Lactating Individuals (COVERED)

The goal of this program is to monitor the attitudes, safety and effectiveness of the various vaccines for those who are pregnant and lactating. Through this survey, we will document vaccine safety for those who are pregnant and lactating. This project is endorsed by COVID-19 Immunity Task Force and funded by Public Health Agency of Canada.